.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A prospective randomized study evaluated whether additional manipulation of the inverted internal limiting membrane (ILM) flap is necessary after the flap has been placed over a large stage IV idiopathic macular hole. Patients were randomized to a classic inverted flap technique or a modified approach in which the flap was not trimmed, tucked, or massaged after inversion. At 12 months, macular hole closure was extremely high in both groups, with nearly identical closure rates. Visual and outer-retinal structural outcomes were also broadly similar. The practical importance of this work is that it challenges the assumption that more surgical manipulation necessarily improves anatomical success. For surgeons, reducing unnecessary handling may simplify the procedure and potentially decrease the risk of flap displacement or retinal trauma. The findings are particularly relevant in training environments because they help focus attention on the key steps that create a stable scaffold while avoiding technically complex maneuvers that may not add measurable benefit. As with all macular-hole evidence, case selection matters, and results in large stage IV holes may not translate directly to smaller holes, high myopia, traumatic holes, or chronic holes.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A prospective randomized study evaluated whether additional manipulation of the inverted internal limiting membrane (ILM) flap is necessary after the flap has been placed over a large stage IV idiopathic macular hole. Patients were randomized to a classic inverted flap technique or a modified approach in which the flap was not trimmed, tucked, or massaged after inversion. At 12 months, macular hole closure was extremely high in both groups, with nearly identical closure rates. Visual and outer-retinal structural outcomes were also broadly similar. The practical importance of this work is that it challenges the assumption that more surgical manipulation necessarily improves anatomical success. For surgeons, reducing unnecessary handling may simplify the procedure and potentially decrease the risk of flap displacement or retinal trauma. The findings are particularly relevant in training environments because they help focus attention on the key steps that create a stable scaffold while avoiding technically complex maneuvers that may not add measurable benefit. As with all macular-hole evidence, case selection matters, and results in large stage IV holes may not translate directly to smaller holes, high myopia, traumatic holes, or chronic holes.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
